A citation-based method for searching scientific literature

Mehryar Taban, David S Boyer, Edgar L Thomas, Mehran Taban. Am J Ophthalmol 2004
Times Cited: 130







List of co-cited articles
481 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Photodynamic therapy for chronic central serous chorioretinopathy.
Felice Cardillo Piccolino, Chiara M Eandi, Luca Ventre, Roberta C Rigault de la Longrais, Federico M Grignolo. Retina 2003
248
68


Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.
Lawrence A Yannuzzi, Jason S Slakter, Nicole E Gross, Richard F Spaide, Danielle L L Costa, Sheau J Huang, James M Klancnik, Alexander Aizman. Retina 2003
295
64

Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.
Wai-Man Chan, Timothy Y Y Lai, Ricky Y K Lai, Emily W H Tang, David T L Liu, Dennis S C Lam. Retina 2008
174
48

Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.
Wai-Man Chan, Timothy Y Y Lai, Ricky Y K Lai, David T L Liu, Dennis S C Lam. Ophthalmology 2008
213
46

Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial.
Michele Reibaldi, Nicola Cardascia, Antonio Longo, Claudio Furino, Teresio Avitabile, Salvatore Faro, Marisa Sanfilippo, Andrea Russo, Maurizio Giacinto Uva, Ferdinando Munno,[...]. Am J Ophthalmol 2010
168
46


Digital indocyanine green videoangiography of central serous chorioretinopathy.
D R Guyer, L A Yannuzzi, J S Slakter, J A Sorenson, A Ho, D Orlock. Arch Ophthalmol 1994
477
42




Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.
Ursula Schlötzer-Schrehardt, Arne Viestenz, Gottfried O H Naumann, Horst Laqua, S Michels, Ursula Schmidt-Erfurth. Graefes Arch Clin Exp Ophthalmol 2002
204
31

Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy.
Roy H Loo, Ingrid U Scott, Harry W Flynn, J Donald M Gass, Timothy G Murray, Mary Lou Lewis, Phillip J Rosenfeld, William E Smiddy. Retina 2002
267
28


Central serous chorioretinopathy.
Maria Wang, Inger Christine Munch, Pascal W Hasler, Christian Prünte, Michael Larsen. Acta Ophthalmol 2008
390
26


Photodynamic therapy in chronic central serous chorioretinopathy.
M Battaglia Parodi, S Da Pozzo, G Ravalico. Retina 2003
75
33

Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy.
Michael D Ober, Lawrence A Yannuzzi, Diana V Do, Richard F Spaide, Neil M Bressler, Lee M Jampol, Allison Angelilli, Chiara M Eandi, Alice T Lyon. Ophthalmology 2005
76
30


Indocyanine green videoangiography of older patients with central serous chorioretinopathy.
R F Spaide, L Hall, A Haas, L Campeas, L A Yannuzzi, Y L Fisher, D R Guyer, J S Slakter, J A Sorenson, D A Orlock. Retina 1996
296
22


The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.
Felice Cardillo Piccolino, Roberta Rigault de la Longrais, Giambattista Ravera, Chiara M Eandi, Luca Ventre, Ali' Abdollahi, Marilisa Manea. Am J Ophthalmol 2005
233
22


Prognostic factors related to photodynamic therapy for central serous chorioretinopathy.
Jun Woong Moon, Hyeong Gon Yu, Tae Wan Kim, Hyung Chan Kim, Hum Chung. Graefes Arch Clin Exp Ophthalmol 2009
63
31

Long-term follow-up of central serous chorioretinopathy.
C M Gilbert, S L Owens, P D Smith, S L Fine. Br J Ophthalmol 1984
236
20

Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.
Arif Koytak, Kazim Erol, Erol Coskun, Nihal Asik, Hakan Öztürk, Yusuf Özertürk. Retina 2010
38
52

Central serous chorioretinopathy in younger and older adults.
R F Spaide, L Campeas, A Haas, L A Yannuzzi, Y L Fisher, D R Guyer, J S Slakter, J A Sorenson, D A Orlock. Ophthalmology 1996
343
19

Acetazolamide for central serous retinopathy.
Joseph Pikkel, Itzchak Beiran, Avinoam Ophir, Benjamin Miller. Ophthalmology 2002
81
23


Low-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophy.
M Reibaldi, F Boscia, T Avitabile, A Russo, V Cannemi, M G Uva, A Reibaldi. Eur J Ophthalmol 2009
34
55

Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy.
Christina Canakis, Charalampos Livir-Rallatos, Zafirakis Panayiotis, Gerasimos Livir-Rallatos, Efstratios Persidis, Mandi D Conway, Gholam A Peyman. Am J Ophthalmol 2003
46
39

Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin.
Ming-Wei Zhao, Peng Zhou, Hong-Xiang Xiao, Yong-Shun Lv, Chun-An Li, Guo-Dong Liu, Xiao-Xin Li. Retina 2009
52
34

Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.
Yutaka Imamura, Takamitsu Fujiwara, Ron Margolis, Richard F Spaide. Retina 2009
675
18



Histopathological changes following photodynamic therapy in human eyes.
Ursula Schmidt-Erfurth, Horst Laqua, Ursula Schlötzer-Schrehard, Arne Viestenz, Gottfried O H Naumann. Arch Ophthalmol 2002
195
17


Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
Ichiro Maruko, Tomohiro Iida, Yukinori Sugano, Akira Ojima, Masashi Ogasawara, Richard F Spaide. Ophthalmology 2010
335
17

Central serous chorioretinopathy: update on pathophysiology and treatment.
Benjamin Nicholson, Jason Noble, Farzin Forooghian, Catherine Meyerle. Surv Ophthalmol 2013
360
17

Risk factors for central serous chorioretinopathy: a case-control study.
Robert Haimovici, Sean Koh, David R Gagnon, Todd Lehrfeld, Sarah Wellik. Ophthalmology 2004
296
16

A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports).
Mitzy E Torres-Soriano, Gerardo García-Aguirre, Verónica Kon-Jara, Orlando Ustariz-Gonzáles, Maura Abraham-Marín, Michael D Ober, Hugo Quiroz-Mercado. Graefes Arch Clin Exp Ophthalmol 2008
60
26

Retinal atrophy in idiopathic central serous chorioretinopathy.
Maria S M Wang, Birgit Sander, Michael Larsen. Am J Ophthalmol 2002
138
16

Intravitreal bevacizumab injection for central serous chorioretinopathy.
Su Jin Lim, Mi In Roh, Oh Woong Kwon. Retina 2010
70
21


Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy.
Massimo Nicoló, Chiara M Eandi, Camilla Alovisi, Federico M Grignolo, Carlo Enrico Traverso, Donatella Musetti, Felice Cardillo Piccolino. Am J Ophthalmol 2014
82
18

Photodynamic therapy for chronic central serous chorioretinopathy.
José M Ruiz-Moreno, Francisco L Lugo, Felix Armadá, Rufino Silva, Javier A Montero, J Fernando Arevalo, Luis Arias, Francisco Gómez-Ulla. Acta Ophthalmol 2010
52
26


Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study.
Ozgur Artunay, Erdal Yuzbasioglu, Rifat Rasier, Alper Sengul, Halil Bahcecioglu. Curr Eye Res 2010
56
23

The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy.
Ji Won Lim, Su Jeong Ryu, Min Cheol Shin. Korean J Ophthalmol 2010
48
27

A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy.
So Hyun Bae, Jang Won Heo, Cinoo Kim, Tae Wan Kim, Joo Yong Lee, Su Jeong Song, Tae Kwann Park, Sang Woong Moon, Hum Chung. Am J Ophthalmol 2011
59
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.